Final Stages Of Metastatic Prostate Cancer

Stage 4 Prostate Cancer Life Expectancy

Living with advanced prostate cancer

The five year survival rate for stage 1 prostate cancer is 100%, but stage 4 prostate cancer life expectancy is not very encouraging. While providing information on late stage prostate cancer life expectancy, this HealthHearty article also describes what is meant by staging and grading of prostate cancer.

Statistics show that more and more men are being diagnosed with prostate cancer every year. Various tests like PSA test, DRE test, ultrasound sonography, etc., help diagnose the cancer. Staging and grading of cancer not only help design the treatment but they also help determine how well the cancer may respond to the treatment. Staging, generally, is concerned with the spread of cancer. The Gleason grading system involves classification of cancer cells. It helps determine aggressiveness of the cells and their likelihood of spreading.

What Are The Stages Of Prostate Cancer

Cancer staging is first described using what is called a TNM system. The âTâ refers to a description of the size or extent of the primary, or original, tumor. âNâ describes the presence or absence of, and extent of spread of cancer to lymph nodes that may be nearby or further from the original tumor. âMâ describes the presence or absence of metastases â usually distant areas elsewhere in the body other than regional lymph nodes to which cancer has spread. Cancers with specific TNM characteristics are then grouped into stages, and the stages are then assigned Roman numerals with the numerals used in increasing order as the extent of the cancer being staged increases or the cancer prognosis worsens. Prognosis is finally reflected by considering the patientâs PSA score at presentation as well as their Gleason score in assigning a final stage designation.

The American Joint Commission on Cancer system for prostate cancer staging is as follows:

The primary tumor

Traditionally, advanced prostate cancer was defined as a disease that had widely metastasized beyond the prostate, the surrounding tissue, and the pelvic lymph nodes and was incurable. However, a more contemporary definition includes patients with the lower-grade disease with an increased risk of progression and/or death from prostate cancer in addition to those with widely metastatic disease.

CT scan is used for the initial staging in select patients including

The regional lymph nodes

Stage Iv Prostate Cancer Prognosis

Prostate cancers detected at the distant stage have an average five-year survival rate of 28 percent, which is much lower than local and regional cancers of the prostate. This average survival rate represents stage IV prostate cancers that have metastasized beyond nearby areas to lymph nodes, organs or bones in other parts of the body.

Prognostic Nomogram For Css

Compared with the nomogram for OS, the nomogram for CSS integrating all the significant independent factors including AJCC stage based on the training cohort is shown in Figure 6B. The C-index for nomogram of CSS prediction was 0.838 , and 0.852 in the training and validation cohort, respectively. The calibration plots indicated an excellent accuracy in prediction for CSS probability at 5 and 10 year in the training cohort and testing cohort .

What Is Advanced Prostate Cancer

When prostate cancer spreads beyond the prostate or returns after treatment, it is often called advanced prostate cancer.

Prostate cancer is often grouped into four stages, with stages III and IV being more advanced prostate cancer.

Early Stage | Stages I & II: The tumor has not spread beyond the prostate.
Locally Advanced | Stage III: Cancer has spread outside the prostate but only to nearby tissues.
Advanced | Stage IV: Cancer has spread outside the prostate to other parts such as the lymph nodes, bones, liver or lungs.

When an early stage prostate cancer is found, it may be treated or placed on surveillance . Advanced prostate cancer is not curable, but there are many ways to treat it. Treatment can help slow advanced prostate cancer progression.

There are several types of advanced prostate cancer, including:

Biochemical Recurrence

With biochemical recurrence, the prostate-specific antigen level has risen after treatment using surgery or radiation, with no other sign of cancer.

Castration-Resistant Prostate Cancer

Non-Metastatic Castration-Resistant Prostate Cancer

Prostate cancer that no longer responds to hormone treatment and is only found in the prostate. This is found by a rise in the PSA level, while the testosterone level stays low. Imaging tests do not show signs the cancer has spread.

Metastatic Prostate Cancer

Lymph nodes outside the pelvis
Bones
Other organs, such as liver or lungs

Metastatic Hormone-Sensitive Prostate Cancer

Possible Changes In Body Function

Profound weakness usually the patient cant get out of bed and has trouble moving around in bed
Needs help with nearly everything
Less and less interest in food, often with very little food and fluid intake for days
Trouble swallowing pills and medicines
More drowsiness the patient may doze or sleep much of the time if pain is relieved, and may be hard to rouse or wake
Lips may appear to droop
Short attention span, may not be able to focus on whats happening
Confusion about time, place, or people
Limited ability to cooperate with caregivers
Sudden movement of any muscle, jerking of hands, arms, legs, or face

White Patients Derive A Larger Conditional Mortality Benefit Than Non

In order to determine whether race interacted with survival, we repeated our initial analyses after stratifying by race and by modeling an interaction term. Among patients with M1 disease, conditional mortality was similar between white and non-white patients . However, among patients with N1 disease, non-white patients did not have a significant reduction in conditional mortality at 5, 10, or 15 years of survival compared to diagnosis , while white patients had similar mortality as the overall cohort, with adjusted hazard ratios of 1.10 , 0.898 , and 0.712 , respectively. While non-white patients with T4 disease had improved 5-year PCSM after having survived 5, 10, or 15 years, their improvements were 20-39 % smaller than those of white patients .

Recommended Reading: Psa 4 After Prostate Removal

Frequently Asked Questions About Metastatic Prostate Cancer

If you have been diagnosed with late-stage prostate cancer, you likely have a number of questions about this malignancy and what you can expect moving forward. To help answer some of your initial questions, you may find it useful to browse the following articles:

What should I expect with treatment for metastatic prostate cancer?

While these articles may help provide general information about metastatic prostate cancer, it is best to discuss your individual condition and specific questions with a physician to receive medical advice that is tailored to your unique circumstances. At Moffitt Cancer Center, the multispecialty team that makes up our Urologic Oncology Program collaborates in regular tumor board meetings to provide our patients with individualized treatment plans that lead to better outcomes and an improved quality of life.

Medically reviewed by Monica Chatwal, MD.

Moffitt welcomes patients with or without a referral to learn more about their metastatic prostate cancer diagnosis and treatment options. To schedule an appointment, call or fill out a new patient registration form online.

BROWSE

What Is Prostate Cancer

How Cancer Spreads (Metastasis) – Michael Henry, PhD

Prostate cancer is cancer that affects the prostate gland in men. Prostate cancer is the second-leading cause of cancer deaths for men in the US.

The prostate lies below the bladder and in front of the rectum. In men, the size of the prostate increases with increasing age. In younger men, it is about the size of a walnut. Its primary function is to make fluid to nourish the semen.

Growth in the prostate can be of two types

Benign growths: These are noncancerous growths and are rarely a threat to life. For example, benign prostatic hyperplasia.

Malignant growths: These are cancerous growths that can sometimes be life-threatening.

Prostate cancer starts in the prostate gland and may spread to the nearby areas: lymph nodes, organs, or bones in other parts of the body.

Read Also: Genetic Testing Of Prostate Biopsy

Survival Rates For Prostate Cancer

Survival rates can give you an idea of what percentage of people with the same type and stage of cancer are still alive a certain amount of time after they were diagnosed. These rates cant tell you how long you will live, but they may help give you a better understanding of how likely it is that your treatment will be successful.

Keep in mind that survival rates are estimates and are often based on previous outcomes of large numbers of people who had a specific cancer, but they cant predict what will happen in any particular persons case. These statistics can be confusing and may lead you to have more questions. Ask your doctor, who is familiar with your situation, how these numbers may apply to you.

Survival Rates By Tnm Stage

The first approach is based on the TNM stage statistical survival times are matched to the stage of the disease.

TNM Lung Cancer Stage
M1c	6.3 months

By contrast, the one-year survival rate for stage 4 lung cancer was reported in one study to be between 15% and 19%, meaning this portion of patients with metastatic disease lived for at least a year.

What Are Next Steps

Bone metastasis have a profound effect on the long-term outlook for prostate cancer. But its important to remember that the numbers are only statistics.

The good news is that life expectancy for advanced prostate cancer continues to increase. New treatments and therapies offer both longer life and better quality of life. Speak to your doctor about your treatment options and long-term outlook.

Everyones cancer experience is different. You may find support through sharing your treatment plan with friends and family. Or you can turn to local community groups or online forums like Male Care for advice and reassurance.

Understanding Prostate Cancers Progression

To determine the appropriate treatment, doctors need to know how far the cancer has progressed, or its stage. A pathologist, the doctor trained in analyzing cells taken during a prostate biopsy, will provide two starting pointsthe cancers grade and Gleason score.

Cancer grade: When the pathologist looks at prostate cancer cells, the most common type of cells will get a grade of 3 to 5. The area of cancer cells in the prostate will also be graded. The higher the grade, the more abnormal the cells.
Gleason score: The two grades will be added together to get a Gleason score. This score tells doctors how likely the cancer is to grow and spread.

After a biopsy confirms prostate cancer, the patient may undergo additional tests to see whether it has spread through the blood or lymph nodes to other parts of the body. These tests are usually imaging studies and may include a bone scan, positron emission tomography scan or computed tomography scan.

Treatment Options Under Clinical Evaluation

Treatment options under clinical evaluation for patients with prostate cancer include the following:

Bicalutamide.

Cryosurgery

Cryosurgery, or cryotherapy, is under evaluation for the treatment of localized prostate cancer. It is a surgical technique that involves destruction of prostate cancer cells by intermittent freezing of the prostate with cryoprobes, followed by thawing. There is limited evidence regarding its efficacy and safety compared with standard prostatectomy and radiation therapy, and the technique is evolving in an attempt to reduce local toxicity and normal tissue damage. The quality of evidence on efficacy is low, currently limited to case series of relatively small size, short follow-up, and surrogate outcomes of efficacy.

Serious toxic effects associated with cryosurgery include bladder outlet injury, urinary incontinence, sexual impotence, and rectal injury. Impotence is common, ranging from about 47% to 100%.

The frequency of other side effects and the probability of cancer control at 5 years follow-up have varied among reporting centers, and series are small compared with surgery and radiation therapy. Other major complications include urethral sloughing, urinary fistula or stricture, and bladder neck obstruction.

Proton-beam therapy

Vascular-targeted photodynamic therapy using a photosensitizing agent has been tested in men with low-risk prostate cancer.

Neoadjuvant hormonal therapy

You May Like: How Is Prostate Test Done

How The Study Was Performed

During the study, scientists randomized 1,071 men with intermediate- or high-risk localized prostate cancer into four groups. One group received radiation and six months of an anti-testosterone drug called leuporelin, and the second group received radiation plus 18 months of leuporelin therapy. Two other groups were treated with the same regimens of either radiation plus six or 18 months of leuporelin therapy, along with another drug called zoledronic acid, which helps to limit skeletal pain and related complications should cancer spread to the bones. Study enrollment occurred between 2003 and 2007 at 23 treatment centers across New Zealand and Australia.

Donât Miss: How Early Can You Get Prostate Cancer

Read Also: How To Treat Inflamed Prostate

Knowing What To Expect In The Final Days Or Hours Helps Comfort The Family

Most people don’t know the signs that show death is near. Knowing what to expect can help them get ready for the death of their loved one and make this time less stressful and confusing. Healthcare providers can give family members information about the changes they may see in their loved one in the final hours and how they may help their loved one through this.

Supportive And Palliative Care For Adults With Cancer

Is Seminal Vesicle Invasion Considered Metastatic Disease? | Mark Scholz, MD | PCRI

The guidance on supportive and palliative care for adults with cancer was published by NICE in March 2004. It placed importance on the holistic approach to managing patients, their carers and relatives following a diagnosis of cancer. In particular, the multidisciplinary team was recognized as key in the process of providing continuity of total care. The importance of working as a multidisciplinary team cannot be stressed enough. To believe that the suffering experienced by patients with a terminal diagnosis can be solely managed by one professional body is foolish. Within the context of the Palliative Care Team, members of the MDT should include those who can deal with physical, spiritual, psychological and social needs. Rehabilitative and nutritional needs should also be recognized and addressed along with the provision of access to complementary therapies.

Recommended Reading: How To Prevent Prostate Cancer Naturally

The Top 7 Signs Of Advanced Prostate Cancer

In the early stages, you may not notice any symptoms related to prostate cancer. This is why screenings are important. Symptoms can sometimes be noticed for the first time when the cancer advances.

Advanced prostate cancer, also called metastatic cancer, means the cancer has spread to other areas of your body beyond your prostate gland. The most common areas for prostate cancer to spread are your bladder, rectum, and bones. It can also spread to your lymph nodes, liver, lungs, and other body tissues.

Whether youve just been diagnosed or youre in treatment, its also important to know the signs of advanced cancer. Cancer can behave differently depending on your genetics, so not every person will experience the same symptoms in the same way.

Read on to learn more about the seven top symptoms of advanced prostate cancer and how to spot them.

Advanced Prostate Cancer Resources

At ZERO we are dedicated to helping you live your best life possible and we have resources and information to help you and your loved ones throughout the advanced prostate cancer journey. Our advanced prostate cancer resources include print materials, online educational programs and co-pay assistance. Check out some of our resources listed below.

Recommended Reading: Does Every Man Get Prostate Cancer

Gleason Score Vs Grade Groups

The International Society of Urological Pathology released a revised prostate cancer grading system in 2014. The grade group system seeks to simplify Gleason scores and give a more accurate diagnosis.

One of the major problems with the Gleason score is that some scores can be made up in different ways. For example, a score of 7 can mean:

3 + 4. The 3 pattern is the most common in the biopsy and 4 is the second most common. This pattern is considered favorable intermediate risk.
4 + 3. The 4 pattern is the most common in the biopsy and 3 is the second most common. This pattern is considered unfavorable and may mean local or metastatic spread.

So, although both situations give a Gleason score of 7, they actually have very different prognoses.

Heres an overview of how the two grading systems compare:

Cancer grade
grade group 5	910

Not all hospitals have switched to the grade group system. Many hospitals give both grade group and Gleason scores to avoid confusion until grade groups become more widely used.

How You Might Feel

IFITM3 promotes bone metastasis of prostate cancer cells by mediating

When prostate cancer is advanced, it can no longer be cured. But treatment can control it for some time and help to relieve symptoms.

Finding out that your cancer cant be cured is distressing and can be a shock. Its common to feel uncertain and anxious. It’s normal not to be able to think about anything else.

Lots of information and support are available to you, your family and your friends. It can help to find out more about your cancer and the treatments you might have. Many people find that knowing more about their situation can make it easier to cope.

Talk to your doctor or nurse to understand:

what your diagnosis means

Don’t Miss: Prostate Removal Pros And Cons